Lmr Partners LLP Veru Inc. Put Options Transaction History

Lmr Partners LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$0.67 - $1.17 $40,267 - $70,317	-60,100 Reduced 26.04%	170,700 $122,000
Q3 2023 Nov 14, 2023	SELL	$0.72 - $1.33 $815,904 - $1.51 Million	-1,133,200 Reduced 83.08%	230,800 $166,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.49 $274,498 - $417,349	-280,100 Reduced 17.04%	1,364,000 $1.62 Million
Q1 2023 May 15, 2023	BUY	$1.16 - $6.41 $1.91 Million - $10.5 Million	1,644,100 New	1,644,100 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $4.54 Million - $10.5 Million	444,400 Added 44.02%	1,454,000 $16.8 Million
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $4.39 Million - $16 Million	1,009,600 New	1,009,600 $11.4 Million

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.